Bone Tumors (Diagnostics)

Molecular Genetics Aid Metastatic Disease Detection

Published in Cancer Weekly, February 8th, 2000

Early metastatic disease may be detectable in blood specimens using molecular genetic methods, according to researchers from the United States.

The use of molecular genetic methods for detection, role diagnostic markers, and prognostic indicators, as well as the molecular pathogenesis of soft tissue and bone tumors was studied recently by A. Slominski and colleagues at Loyola University Medical Center ("Molecular pathology of soft tissue and bone tumors -- A review," Archives of Pathology and Laboratory Medicine, 1999;123(12):1246-1259).

The researchers used studies containing chromosomal or genetic evaluation of bone and soft tissue tumors,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2000-02-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry